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The membrane glycoproteins that characterize human B  lymphocytes and serve to 
distinguish these cells from T cells have been the subject of considerable recent interest. 
The dominant complex of 28,000 and 37,000 daltons is a product of genes mapping in the 
major histocompatibility complex and was initially  recognized through  alloantibodies 
contained in pregnancy sera (1). More recently they have been studied through the use of 
heteroantisera raised against these molecules isolated from B-cell line membranes (2, 3). 
Because of the biologic and chemical homologies to the murine I region antigen system 
(Ia) the 28,000-37,000  dalton complex in man has been termed "Ia-like" or for simplicity 
"Ia". 
From the earliest studies relating the presence of the Ia alloantigens to circulating B 
cells,  it was evident that certain nonlymphoid cells of hematopoietic origin expressed 
these determinants (1). The recognition of the Ia determinants on monocytes (1, 2) was 
followed by their demonstration on malignant (2, 4, 5) and normal myeloblasts (6, 7), as 
well  as  on  the  stem  cells  that  were  the  committed  progenitors  of granulocyte  and 
macrophage (CFU-C) colonies (6, 8). In the granulocyte lineage, the Ia antigens became 
undetectable after the promyelocyte stage (6, 8). 
In a  previous study it was demonstrated that Ia antigens were expressed on 
the surface membrane of some cells with the appearance of pronormoblasts or 
basophilic normoblasts  (6),  but were not present on members of the erythroid 
series that were more mature than basophilic normoblasts. 
The present study sought to document the presence of Ia determinants on the 
erythropoietin-sensitive progenitor cells committed to differentiation into these 
erythroid cells. Assays were performed on two cells in this lineage distinguish- 
able by the kinetics and properties of the colonies they gave rise to: the colony 
and burst-forming cells (CFU-E and BFU-E, respectively) (9). 
Materials and Methods 
Bone Marrow Preparation.  Bone marrow was obtained from normal volunteers who had given 
informed consent. Washed bone marrow buffy coat cells were mixed with bovine serum albumin 
(1.070 g/cm  3 density, 270 mosM) over which bovine serum albumin at a density of 1.050 g/cm  3 was 
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layered. The gradient was centrifuged at 3,600 g for 10 min and the supernatant cells present in 
the lower density fraction were harvested and washed as described previously (10). A nonadherent 
population of the low density cell fraction was prepared by sequential adherence on plastic tissue 
culture Petri dishes as described (10, 11). 10-20% of the cells in the low density fraction were 
removed by this procedure.  >98% of the erythroid and myeloid progenitors present in the whole 
marrow sample were recovered in the low density nonadherent preparation. 
Lymphoid Lines.  Lymphoid lines were maintained in culture in medium RPMI-1640 supple- 
mented with 10% fetal calf serum (Reheis Chemical Co., St. Louis, Mo.). They were harvested and 
washed four times with Dulbecco's saline. The B-cell pool was formed from Epstein-Barr virus 
transformed lymphocytes obtained from six normal subjects.  The T-cell pool consisted of CEM-T, 
MOLT-4, and 1301. 
Ia Specific Antiserum.  Ia specific  antiserum was prepared by immunizing rabbits with a 
65,000 dalton bimolecular glycoprotein complex isolated from the membranes of B35M, a B-cell 
lymphoblastoid line. The 65,000 dalton component contained the Ia alloantigenic activity and 
dissociated  to 28,000 and 37,000 dalton polypeptides  upon denaturation at 100°C. The resulting 
antiserum had been previously documented to react with the Ia bimolecular complex (2, 6, 12). 1 
ml of the antiserum was diluted to 1:20 and absorbed with 1 ml of washed,  packed pooled T-cell 
lymphoid lines. In the case of the B-cell-absorbed control sample, 2 ml of washed packed B cells 
were added to the packed  T cells and a single absorption was performed.  The cells and diluted 
serum were incubated at 4°C with frequent resuspension. The cells were removed by centrifuga- 
tion (10 rain, 8,000 g) and the diluted serum passed through a 0.22 ~m Millipere filter (Millipore 
Corp., Bedford, Mass.). 
Complement-Dependent Cytotoxicity.  Dilutions of antiserum or control serum were prepared 
in McCoy's serum supplemented  with 10% fetal calf  serum. Cells (2 x 106) in 0.4 ml were incubated 
with 0.4 ml of diluted antiserum at 4°C for 30 min. They were washed once by layering on a 2-ml 
cushion of fetal calf serum and incubated at 37°C for 45 min with 0.4 ml of rabbit complement 
diluted 1:10 that was previously selected  for the absence of heterospecific  antibodies. The cells 
were washed twice through fetal calf serum cushions and divided for subsequent assays. 
Colony Assays.  Myeloid colony assays were carried out in 0.3% agar in supplemented McCoy's 
medium over a feeder layer of human peripheral leukoeytes in 0.5% agar as previously reported 
(10). Colonies and clusters were scored with the inverted microscope at 7 days. Erythroid colony 
assays were carried out according to the method of Iscove et al. (11, 12). 1 × 10  s light density cells 
or 2 ×  105 nonadherent light density cells were incorporated in each plate. Cells were plated in 
alpha medium containing  a final concentration of 0.8% methylcellulose, 30% fetal calf serum, 1% 
bovine serum albumin, and 1 U/ml of human urinary erythropoietin. The erythropoietin, which 
was kindly supplied by Norman Iscove, had been prepared from the urine of patients with aplastic 
anemia by chromatographic separation, including absorption by concanavalin A-sepharese to 
remove colony stimulating  activity. The final activity of the erythropoietin was 110 U/mg protein. 
Erythroid colony-forming units (CFU-E) and burst-forming units (BFU-E) were scored by using 
the inverted microscope at 7 and 14 days, respectively. The data were based on counting of 10 
replicates for each datum point and are expressed  as mean -+ standard error. Individual colonies 
were plucked and placed  on glass slides.  Staining with benzidine and counter staining with 
Wright-Giemsa confirmed the erythroid nature of the colonies. 
Results 
Table  I  contains the  results  of a  representative experiment  from  a  single 
donor  demonstrating  the  complement-dependent inhibition of erythropoietic 
and granulocyte-macrophage colony formation by the Ia antiserum. The cloning 
efficiency of erythropoietin-dependent colonies, arising from CFU-E, and bursts, 
arising from BFU-E,  were  0.22  and 0.56%,  respectively, in this light density 
nonadherent  fraction  of normal  bone  marrow.  Incubation with  complement 
alone caused slight inhibition of erythroid colony formation. Substantial inhi- 
bition  of  CFU-E  and  BFU-E  assays  resulted  after  incubation with  the  Ia 
antiserum which was prepared with T-cell lymphoid line absorption, followed 
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TABLB  I 
Complement Dependent Inhibition by Antiserum to Ia Determinants of Erythropoietic 
and Granulocytic Colony Formation by Bone Marrow Cells 
Treatment  of bone marrow cells 
Colonies per 2  x  l(P/plate 
CFU-E (7 days)  BFU-E (13 days)  CFU-C (7 days) 
Medium 
Complement 
Anti-Ia serum 1:40 +  complement 
Anti-Ia serum 1:160 +  complement 
Anti-Ia serum 1:640 +  complement 
Anti-Ia serum 1:2500 +  complement 
Anti-Ia serum 1:10,000 +  complement 
Anti-Ia serum 1:40,000 +  complement 
Anti-la serum 1:160,000 +  complement 
Anti-Ia serum 1:40 absorbed with B cells +  complement 
444 ±  14  113 ±  2  387 +- 9 
400 ±  15  102 ±  I0  388 -,- 17 
41+-5  5--2  13±2 
49±5  12--.2  41--.4 
69 ±  8  20-  3  141 ±  5 
71 ±  7  33 -  4  238 -  4 
105 ±  6  47 "- 3  308 ±  5 
213 "" 8  63 -  1  390 -- 8 
384 ±  12  92 ±  4  380 ±  10 
367 ±  15  98 ±  12  375 ±  22 
antiserum of 1:40,000 for the CFU-E and BFU-E assays. The inhibition of the Ia 
antiserum on colony formation was specifically abolished by absorption with 
pooled  B-cell  lymphoid  lines,  giving  a  cloning  efficiency not  significantly 
different from that obtained with complement alone.  As a  control for these 
experiments granulocyte-macrophage (CFU-C) colonies were also assayed on 
the  same  samples  of bone  marrow after treatment with  Ia  antiserum and 
complement.  Specific  inhibition  of CFU-C  colonies  scored  after  7  days  of 
incubation was found up to a dilution of 1:10,000. Similar results were obtained 
in three other identical experiments by using different normal bone marrow 
donors with comparable titers of inhibition obtained in each experiment for 
each of the progenitor cell assays. 
Experiments done using the light density fraction of normal bone marrow 
before removal of adherent cells gave a cloning efficiency  for CFU-E and BFU-E 
of 0.16 and 0.029, respectively. These colonies were inhibited at titers of anti-Ia 
antiserum equivalent to  those obtained with the nonadherent light density 
fraction. 
Discussion 
The present studies demonstrated that erythropoietic bursts  and colonies, 
arising from the more primitive BFU-E, as well as the relatively more mature 
CFU-E, were both essentially eliminated by antisera specific for Ia determi- 
nants. The marked sensitivity to the anti-Ia antiserum of both of these distinct 
erythroid progenitors was comparable and furthermore was similar to that of 
the cell that is the progenitor of granulocyte-macrophage  colonies (CFU-C). The 
specificity of these reactions was demonstrated by abolishing the  inhibition 
through absorption with B but not T-cell lymphoid lines. In view of  these results 
and the large numbers of previous studies demonstrating the specificity of this 
antiserum  (2,  6,  13),  it  appears  likely that  the  inhibition  of the  erythroid 
precursor colonies is mediated through elimination of Ia bearing cells. 
One point regarding the interpretation of these findings is whether the Ia 
antiserum is reacting directly with Ia determinants expressed on the erythroid 
progenitors or whether colony formation depends on an essential accessory cell 
bearing Ia determinants that would have been eliminated by the antiserum 
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erythropoietic progenitors comes from the evidence that cells with the appear- 
ance of the subsequent stages in the erythroid  ]ineage-proerythroblasts  and 
basophilic nomoblasts-express Ia determinants  on their membranes (6).  Fur- 
thermore there has thus far been no evidence for the participation of an accessory 
cell  likely  to  bear  Ia  antigens  in  erythropeietic  colony  formation.  Recent 
evidence by Nathan eta].  (14) has implicated a soluble component produced by 
a cell in the T-cell fraction as an enhancing factor in generation of BFU-E from 
progenitors circulating in peripheral blood. However, since the vast majority of 
cells isolated by sheep erythrocyte rosette formation do not react with anti-Ia 
sera  it  is  very  unlikely  that  the  inhibition  was  mediated  through  T  cells. 
Indeed,  the antiserum  is employed only after T-cell lymphoid line absorption. 
Therefore  the  pattern  in  the  erythroid  lineage  of Ia  antigen  expression  on 
progenitor cells and the first cytologically distinct stages of maturation, followed 
by the disappearance of these antigens on the more mature stages appears to be 
precisely analogous to the finding in the granulocyte lineage (2, 4, 8). 
Particularly  with respect to the granulocytic lineage,  it appears that there 
are some differences in Ia antigen expression between the findings in man and 
in the murine studies. Basch et al. (15) concluded that Ia determinants were not 
expressed on the pleuripetentia] stem cell, CFU-S. Furthermore,  Kincade et al. 
reported that CFU-C are not eliminated by an anti-Ia (murine) serum (16). It is 
unlikely that  the relatively minor differences in reagent  preparation  account 
for this divergence. The anti-Ia (human) heteroantiserum used in these studies 
was prepared by immunization with a  65,000 dalton complex that contains the 
alloantigenic  activity  obtained  from  B-cell  lymphoid  lines.  The  murine  Ia 
reagents have usually been prepared by intraspecies immunization  and recog- 
nize a  very similar bimolecular complex (17) with many points of genetic and 
biologic homology with the human system. 
Furthermore,  the studies on the presence of Ia antigens on progenitors and 
early members of the normal human granulocyte lineage using various anti-Ia 
heterosera  were  strengthened  considerably  by the  use of cells  from  patients 
with granulocytic leukemias. These ]eukemias permitted more extensive docu- 
mentation  of the chemical  and  allo-antigenic  characteristics  of the  Ia system 
present  on the  myeloblast stage than  would be possible on the  more limited 
material available from normal bone marrow. Thus the demonstration that the 
anti-Ia  heteroantisera  identified the bimolecul~r complex of 28,000 and 37,000 
daltons  on radiolabeled  myeloblasts  (6),  as well as the  selective reactivity of 
these cells with a panel of selected Ia specific alloantisera  (2, 6) provide strong 
evidence for the Ia nature of these determinants on the myeloblasts and support 
the interpretation that the inhibition of the granulocyte-macrophage progenitor 
cells is due to the Ia specificity of the hetero anti-Ia reagents. 
Thus  it  appears  that  in  man  the  Ia  system  is  more  broadly expressed  on 
various progenitor cells and very early members of the major marrow lineages 
than has been reported in the mouse. In this context the findings of the present, 
as  well as  previous studies,  raise  the  question of the  function  served by the 
occurrence of the Ia molecule on cells derived from the bone marrow that do not 
serve  a  primary  immune  function.  One  possibility  is  the  conjecture  that  Ia 
determinants have a function relating to the control of proliferation within the 
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Summary 
Incubation with Ia antiserum, followed by complement, markedly inhibited 
erythroid colonies arising from hematopoietic cells present in the nonadherent 
low density fractions of normal bone marrow.  Both erythropoietin-dependent 
colonies and bursts were eliminated at dilutions of antiserum equivalent to, or 
greater  than  the  dilutions required  to  abolish  the  granulocyte-macrophage 
colony formation. The inhibitory effect of the Ia antiserum was abolished by 
absorption  with B  but  not  T  cells  from  lymphoid lines.  Available evidence 
suggested that Ia determinants are expressed on the erythropoietin-sensitive 
progenitors  of the  erythroid  series  in  precise  analogy to  their  sequence  of 
expression on the granulocyte lineage. In both lineages, as shown previously, 
the Ia determinants become undetectable during subsequent stages of differen- 
tiation. 
Received tor publication 1 May 1978. 
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